Guest guest Posted December 21, 2010 Report Posted December 21, 2010 Hoffman-Roche/Genentech has announced a new FCR clinical trial for CLL patients that are 65 years and over and NOT previously treated. There are no clinical trials sites announced yet. Health Authority: Israel: Ministry of Health, Pharmaceutical Administration Inclusion Criteria: Adult patients, >/= 65 years of age Previously untreated B-cell chronic lymphocytic leukemia (CLL) Binet stage C or active Binet stage A and B disease Exclusion Criteria: Prior treatment for CLL CLL with transformation (Richter's syndrome) Suspected or known CNS involvement of CLL Impaired renal or hepatic function HIV positivity, active hepatitis B/C, or any active or uncontrolled infections Concomitant diseases requiring chronic steroid administration Active second malignancy within the 2 years prior to study (except for non-melanoma skin cancer and in situ cervix or breast carcinoma) ECOG performance status >/= 4 Trial Number:NCT01263704 Link: http://clinicaltrials.gov/ct2/show/NCT01263704?term=CLL & recr=Open & rcv_d=14 CLL CANADA http:/cllcanada.ca Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.